Evidence map›Paper›PMID 38256880›Full record

ArticlePharmaceuticals (Basel, Switzerland)2023

Paulo Gaio, Allysson Cramer, Natália Fernanda de Melo Oliveira, Samuel Porto, Lucas Kramer, Rayane Aparecida Nonato Rabelo, Rafaela das Dores Pereira, Laura Lis de Oliveira Santos, César Luís Nascimento Barbosa, Fabrício Marcus Silva Oliveira and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Paulo GaioDepartment of Biochemistry and Immunology, Institute of Biological Science, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil.ORCID 0000-0003-3753-9547
Allysson CramerDepartment of Biochemistry and Immunology, Institute of Biological Science, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil.ORCID 0000-0002-5682-3773
Natália Fernanda de Melo OliveiraDepartment of Biochemistry and Immunology, Institute of Biological Science, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil.
Samuel PortoDepartment of Biochemistry and Immunology, Institute of Biological Science, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil.
Lucas KramerDepartment of Biochemistry and Immunology, Institute of Biological Science, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil.
Rayane Aparecida Nonato RabeloDepartment of Biochemistry and Immunology, Institute of Biological Science, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil.
Rafaela das Dores PereiraDepartment of Biochemistry and Immunology, Institute of Biological Science, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil.
Laura Lis de Oliveira SantosDepartment of Biochemistry and Immunology, Institute of Biological Science, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil.
César Luís Nascimento BarbosaProgram in Health Sciences, Infectious Diseases and Tropical Medicine/Interdisciplinary Laboratory of Medical Investigation, Faculty of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte 30130-100, MG, Brazil.
Fabrício Marcus Silva OliveiraCellular and Molecular Immunology Group, René Rachou Institute, Oswald o Cruz Foundation-FIOCRUZ, Belo Horizonte 30190-002, MG, Brazil.
Mauro Martins TeixeiraDepartment of Biochemistry and Immunology, Institute of Biological Science, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil.ORCID 0000-0002-6944-3008
Remo Castro RussoLaboratory of Pulmonary Immunology and Mechanics, Department of Physiology and Biophysics, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270-901, MG, Brazil.ORCID 0000-0002-1715-3834
Maria João MatosDepartamento de Química Orgánica, Facultad de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.ORCID 0000-0002-3470-8299
Fabiana Simão MachadoDepartment of Biochemistry and Immunology, Institute of Biological Science, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil.
Universidade Federal de Minas Gerais · BRFundação Oswaldo Cruz · BRUniversidade de Santiago de Compostela · ES

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES-Brazil), National Institute for Science and Technology in Dengue and Host-microbial interactions APQ-03606-17Fundação de Amparo a Pesquisa de Minas Gerais FAPEMIG: APQ-02331-18; APQ-01816-23Ministerio de Ciencia e Innovación PID2020-116076RJ-I00/AEI/10.13039/501100011033National Council for Scientific and Technological Development 307828/2022-0Rede de Investigação em Mucosas e Pele RED-00096-22Rede Mineira de Imunobiológicos RED-00140-16
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acute respiratory distress syndromecerebral malariaimmunoregulationN-(coumarin-3-yl)cinnamamidePlasmodium berghei ANKA

Identifiers

PMID38256880
PMCPMC10821074
OpenAlexW4390266608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.